Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Guillon

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
The Journal of Biological Chemistry|March 25, 1986
Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretionA Enjalbert, F Sladeczek, G Guillon, et al.
Endocrine Research|January 15, 1999
Vasopressin : a potent autocrine/paracrine regulator of mammal adrenal functionsG Guillon, E Grazzini, M Andrez, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Vasopressin regulates adrenal functions by acting through different vasopressin receptor subtypesE Grazzini, G Boccara, D Joubert, et al.
Anesthesia and Analgesia|August 10, 1999
The relationship among carbon dioxide pneumoperitoneum, vasopressin release, and hemodynamic changesC Mann, G Boccara, Y Pouzeratte, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Vasopressin receptors in human adrenal medulla and pheochromocytomaE Grazzini, C Breton, S Derick, et al.
Journal of Neuroendocrinology|April 20, 2004
The discovery of novel vasopressin V1b receptor ligands for pharmacological, functional and structural investigationsG Guillon, S Derick, A Pena, et al.
Endocrinology|November 26, 2002
[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptorsS Derick, L L Cheng, M J Voirol, et al.
The Journal of Clinical Investigation|December 15, 1996
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonistC Serradeil-Le Gal, C Lacour, G Valette, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 31, 2009
VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonistL Rihakova, C Quiniou, F F Hamdan, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
The Journal of Biological Chemistry|March 25, 1986
Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretionA Enjalbert, F Sladeczek, G Guillon, et al.
Endocrine Research|January 15, 1999
Vasopressin : a potent autocrine/paracrine regulator of mammal adrenal functionsG Guillon, E Grazzini, M Andrez, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Vasopressin regulates adrenal functions by acting through different vasopressin receptor subtypesE Grazzini, G Boccara, D Joubert, et al.
Anesthesia and Analgesia|August 10, 1999
The relationship among carbon dioxide pneumoperitoneum, vasopressin release, and hemodynamic changesC Mann, G Boccara, Y Pouzeratte, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Vasopressin receptors in human adrenal medulla and pheochromocytomaE Grazzini, C Breton, S Derick, et al.
Journal of Neuroendocrinology|April 20, 2004
The discovery of novel vasopressin V1b receptor ligands for pharmacological, functional and structural investigationsG Guillon, S Derick, A Pena, et al.
Endocrinology|November 26, 2002
[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptorsS Derick, L L Cheng, M J Voirol, et al.
The Journal of Clinical Investigation|December 15, 1996
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonistC Serradeil-Le Gal, C Lacour, G Valette, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 31, 2009
VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonistL Rihakova, C Quiniou, F F Hamdan, et al.
Pageof 11